Back
GDS Holdings Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
64
GDS
GDS Holdings
Last Price:
$39.52
Seasonality Move:
-2.59%
Sell
30
DRUG
Bright Minds Biosciences
Last Price:
$35.58
Seasonality Move:
-44.9%
Buy
64
GDS Holdings (GDS)
is a Buy
Is GDS Holdings a Buy, Sell or Hold?
-
The current GDS Holdings [GDS] share price is $44.75. The Score for GDS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
GDS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $35.99. The Score for DRUG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDS Stock Price Chart
What is GDS Holdings's stock price today?
-
The GDS Holdings share price today is $44.75The current trend is moderately bullish and GDS is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $35.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
GDS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 75.68 | Buy |
Chaikin Money Flow: | -7421209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.67 - 37.35) | Buy |
Bollinger Bands (100): | (17.83 - 28.91) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | -57932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.31 - 42.33) | Sell |
Bollinger Bands (100): | (21.62 - 49.12) | Buy |
GDS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.11 | Buy |
20-day SMA: | 30.76 | Buy |
50-day SMA: | 25.56 | Buy |
200-day SMA: | 17.59 | Buy |
8-day EMA: | 40.34 | Buy |
20-day EMA: | 33.65 | Buy |
50-day EMA: | 27.73 | Buy |
200-day EMA: | 19.65 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.66 | Sell |
20-day SMA: | 37.92 | Sell |
50-day SMA: | 38 | Sell |
200-day SMA: | 18.24 | Buy |
8-day EMA: | 38.81 | Sell |
20-day EMA: | 38.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 23.7 | Buy |
GDS Holdings Earnings Growth & GDS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.32 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
GDS Holdings Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |